Zolla-Pazner S - Search Results

1

Non-neutralizing antibody functions for protection and control HIV in humans and SIV and SHIV in non-human primates.

Zolla-Pazner S. Zolla-Pazner S. AIDS. 2016 Oct 23;30(16):2551-2553. doi: 10.1097/QAD.0000000000001200. AIDS. 2016. PMID: 27753680 Free PMC article. No abstract available.

2

Response of mononuclear cells from HIV-infected patients to B-cell mitogens: correlation with immunological and clinical features of disease progression.

Edelman AS, Zolla-Pazner S. Edelman AS, et al. AIDS. 1990 Sep;4(9):859-64. doi: 10.1097/00002030-199009000-00004. AIDS. 1990. PMID: 2147550

3

Humoral immunity to HIV, SIV, and SHIV.

Haigwood NL, Zolla-Pazner S. Haigwood NL, et al. AIDS. 1998;12 Suppl A:S121-32. AIDS. 1998. PMID: 9632993 Review. No abstract available.

4

Structural analysis of human and macaque mAbs 2909 and 2.5B: implications for the configuration of the quaternary neutralizing epitope of HIV-1 gp120.

Spurrier B, Sampson JM, Totrov M, Li H, O'Neal T, Williams C, Robinson J, Gorny MK, Zolla-Pazner S, Kong XP. Spurrier B, et al. Structure. 2011 May 11;19(5):691-9. doi: 10.1016/j.str.2011.02.012. Structure. 2011. PMID: 21565703 Free PMC article.

5

Identification of antibody glycosylation structures that predict monoclonal antibody Fc-effector function.

Chung AW, Crispin M, Pritchard L, Robinson H, Gorny MK, Yu X, Bailey-Kellogg C, Ackerman ME, Scanlan C, Zolla-Pazner S, Alter G. Chung AW, et al. AIDS. 2014 Nov 13;28(17):2523-30. doi: 10.1097/QAD.0000000000000444. AIDS. 2014. PMID: 25160934 Free PMC article.

6

A fully human antibody to gp41 selectively eliminates HIV-infected cells that transmigrated across a model human blood brain barrier.

McFarren A, Lopez L, Williams DW, Veenstra M, Bryan RA, Goldsmith A, Morgenstern A, Bruchertseifer F, Zolla-Pazner S, Gorny MK, Eugenin EA, Berman JW, Dadachova E. McFarren A, et al. AIDS. 2016 Feb 20;30(4):563-72. doi: 10.1097/QAD.0000000000000968. AIDS. 2016. PMID: 26595540 Free PMC article.

7

Rationally Designed Vaccines Targeting the V2 Region of HIV-1 gp120 Induce a Focused, Cross-Clade-Reactive, Biologically Functional Antibody Response.

Zolla-Pazner S, Powell R, Yahyaei S, Williams C, Jiang X, Li W, Lu S, Wang S, Upadhyay C, Hioe CE, Totrov M, Kong X. Zolla-Pazner S, et al. J Virol. 2016 Nov 28;90(24):10993-11006. doi: 10.1128/JVI.01403-16. Print 2016 Dec 15. J Virol. 2016. PMID: 27630234 Free PMC article.

8

Non-neutralizing Antibodies Alter the Course of HIV-1 Infection In Vivo.

Horwitz JA, Bar-On Y, Lu CL, Fera D, Lockhart AAK, Lorenzi JCC, Nogueira L, Golijanin J, Scheid JF, Seaman MS, Gazumyan A, Zolla-Pazner S, Nussenzweig MC. Horwitz JA, et al. Cell. 2017 Aug 10;170(4):637-648.e10. doi: 10.1016/j.cell.2017.06.048. Epub 2017 Jul 27. Cell. 2017. PMID: 28757252 Free PMC article.

9

Non-neutralizing Antibodies Targeting the V1V2 Domain of HIV Exhibit Strong Antibody-Dependent Cell-mediated Cytotoxic Activity.

Mayr LM, Decoville T, Schmidt S, Laumond G, Klingler J, Ducloy C, Bahram S, Zolla-Pazner S, Moog C. Mayr LM, et al. Sci Rep. 2017 Oct 4;7(1):12655. doi: 10.1038/s41598-017-12883-6. Sci Rep. 2017. PMID: 28978939 Free PMC article.

10

Reduced Cell-Associated DNA and Improved Viral Control in Macaques following Passive Transfer of a Single Anti-V2 Monoclonal Antibody and Repeated Simian/Human Immunodeficiency Virus Challenges.

Hessell AJ, Shapiro MB, Powell R, Malherbe DC, McBurney SP, Pandey S, Cheever T, Sutton WF, Kahl C, Park B, Zolla-Pazner S, Haigwood NL. Hessell AJ, et al. J Virol. 2018 May 14;92(11):e02198-17. doi: 10.1128/JVI.02198-17. Print 2018 Jun 1. J Virol. 2018. PMID: 29514914 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

327 results

Search Page

Filters